X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4463) 4463
Book Review (844) 844
Publication (253) 253
Book Chapter (30) 30
Magazine Article (7) 7
Conference Proceeding (6) 6
Dissertation (5) 5
Newsletter (5) 5
Book / eBook (4) 4
Reference (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3894) 3894
humans (2506) 2506
animals (1684) 1684
macrolides (1627) 1627
female (1448) 1448
male (1438) 1438
anti-bacterial agents - therapeutic use (1032) 1032
pharmacology & pharmacy (1006) 1006
anti-bacterial agents - administration & dosage (811) 811
anti-bacterial agents - pharmacology (767) 767
antibiotics (751) 751
microbiology (723) 723
adult (689) 689
macrolide antibiotics (676) 676
macrolides - therapeutic use (673) 673
infectious diseases (666) 666
azithromycin (649) 649
macrolides - pharmacology (603) 603
macrolides - administration & dosage (600) 600
erythromycin (582) 582
middle aged (564) 564
veterinary sciences (540) 540
treatment outcome (530) 530
clarithromycin (529) 529
macrolide (507) 507
aged (456) 456
research (432) 432
administration, oral (411) 411
mice (379) 379
dosage and administration (358) 358
immunology (358) 358
microbial sensitivity tests (354) 354
adolescent (353) 353
drug therapy (340) 340
pharmacokinetics (332) 332
anti-bacterial agents - adverse effects (326) 326
analysis (325) 325
infections (321) 321
pneumonia (314) 314
child (306) 306
health aspects (306) 306
anti-bacterial agents - pharmacokinetics (304) 304
efficacy (303) 303
parasitology (294) 294
abridged index medicus (276) 276
drug resistance, bacterial (267) 267
cattle (266) 266
dose-response relationship, drug (266) 266
dogs (256) 256
macrolide resistance (248) 248
drug resistance (246) 246
respiratory system (245) 245
time factors (242) 242
care and treatment (241) 241
resistance (236) 236
therapy (231) 231
ivermectin (227) 227
azithromycin - therapeutic use (221) 221
risk factors (221) 221
community-acquired pneumonia (220) 220
infection (218) 218
community-acquired infections - drug therapy (217) 217
children (215) 215
drug administration schedule (212) 212
in-vitro (210) 210
drug therapy, combination (209) 209
child, preschool (207) 207
macrolides - adverse effects (206) 206
moxidectin (201) 201
medicine, general & internal (199) 199
bacteria (191) 191
azithromycin - administration & dosage (188) 188
drug combinations (187) 187
oncology (187) 187
rats (186) 186
drug interactions (185) 185
drug resistance in microorganisms (184) 184
medicine & public health (182) 182
streptococcus-pneumoniae (180) 180
antimicrobial resistance (176) 176
bacterial pneumonia (176) 176
aged, 80 and over (171) 171
clarithromycin - administration & dosage (167) 167
anthelmintics - administration & dosage (166) 166
inflammation (164) 164
erythromycin - pharmacology (162) 162
fluoroquinolones (161) 161
streptococcus pneumoniae - drug effects (156) 156
prevalence (155) 155
roxithromycin (155) 155
infant (153) 153
internal medicine (153) 153
mortality (153) 153
respiratory tract infections - drug therapy (153) 153
clarithromycin - therapeutic use (152) 152
diagnosis (150) 150
pediatrics (150) 150
research article (146) 146
studies (146) 146
antimicrobial agents (145) 145
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4266) 4266
French (70) 70
Japanese (62) 62
German (29) 29
Spanish (25) 25
Russian (14) 14
Chinese (7) 7
Portuguese (6) 6
Korean (4) 4
Danish (3) 3
Dutch (3) 3
Hungarian (3) 3
Italian (3) 3
Bulgarian (2) 2
Croatian (2) 2
Polish (2) 2
Swedish (2) 2
Czech (1) 1
Norwegian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 01/2015, Volume 191, Issue 1, pp. 96 - 103
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2016, Volume 150, Issue 6, pp. 1211 - 1221
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 09/2006, Volume 80, Issue 3, pp. 203 - 215
Objectives: A volunteer trial was performed to compare the pharmacokinetics of 5 drugs-warfarin, ZK253 (Schering), diazepam, midazolam, and erythromycin-when... 
METABOLISM | WARFARIN | ERYTHROMYCIN | PHARMACOLOGY & PHARMACY | PHARMACODYNAMICS | MACROLIDE ANTIBIOTICS | ABSORPTION | PATHOPHYSIOLOGICAL STATES | ACCELERATOR MASS-SPECTROMETRY | BIOAVAILABILITY | DISPOSITION | Estradiol - blood | Estradiol - analogs & derivatives | Injections, Intravenous | Anticoagulants - administration & dosage | Area Under Curve | Humans | Middle Aged | GABA Modulators - pharmacokinetics | Midazolam - administration & dosage | Male | Drug Monitoring - methods | Warfarin - administration & dosage | Diazepam - pharmacokinetics | Dose-Response Relationship, Drug | Aged, 80 and over | Adult | Female | Administration, Oral | Diazepam - administration & dosage | Estradiol - administration & dosage | GABA Modulators - administration & dosage | GABA Modulators - blood | Midazolam - pharmacokinetics | Anticoagulants - blood | Erythromycin - administration & dosage | Warfarin - pharmacokinetics | Cross-Over Studies | Erythromycin - blood | Estradiol - pharmacokinetics | Erythromycin - pharmacokinetics | Midazolam - blood | Warfarin - blood | Adolescent | Diazepam - blood | Aged | Anticoagulants - pharmacokinetics | Chromatography, Liquid - methods | Mass Spectrometry - methods | Carbon Radioisotopes | Warfarin | Dosage and administration | Erythromycin | Health aspects | Diazepam | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Chest, ISSN 0012-3692, 2014, Volume 146, Issue 2, pp. 276 - 282
BACKGROUND There is no large study validating the appropriateness of current treatment guidelines for Mycobacterium avium complex (MAC) lung disease. This is a... 
Pulmonary/Respiratory | RESISTANCE MECHANISMS | CLARITHROMYCIN | NONTUBERCULOUS MYCOBACTERIA | RESPIRATORY SYSTEM | MULTIDRUG REGIMENS | HUMAN-IMMUNODEFICIENCY-VIRUS | NODULAR BRONCHIECTASIS | INTRACELLULARE | HIV-NEGATIVE PATIENTS | PULMONARY-DISEASE | ADVERSE EVENTS | CRITICAL CARE MEDICINE | Sputum - microbiology | Recurrence | Follow-Up Studies | Lung Diseases - microbiology | Humans | Male | Azithromycin - administration & dosage | Lung Diseases - drug therapy | Mycobacterium avium-intracellulare Infection - microbiology | Dose-Response Relationship, Drug | Mycobacterium avium Complex - isolation & purification | Clarithromycin - administration & dosage | DNA, Bacterial - analysis | Female | Retrospective Studies | Drug Therapy, Combination | Bronchiectasis - drug therapy | Macrolides - administration & dosage | Drug Administration Schedule | Genotype | Treatment Outcome | Bronchiectasis - microbiology | Electrophoresis, Gel, Pulsed-Field | Mycobacterium avium Complex - genetics | Mycobacterium avium-intracellulare Infection - drug therapy | Aged | Anti-Bacterial Agents - administration & dosage | Practice Guidelines as Topic | Macrolide antibiotics | Care and treatment | Mycobacterium avium complex | Dosage and administration | Bronchiectasis | Research | Index Medicus | Abridged Index Medicus | Original Research
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2016, Volume 63, Issue 8, pp. 1007 - 1016
Background. Solithromycin, a novel macrolide antibiotic with both intravenous and oral formulations dosed once daily, has completed 2 global phase 3 trials for... 
Community-acquired | Clinical trial | Pneumonia | Solithromycin | Streptococcus pneumoniae | clinical trial | MORTALITY | INFECTIOUS DISEASES | CEM-101 | MICROBIOLOGY | IMMUNOLOGY | PROTEIN-SYNTHESIS | solithromycin | DIFFICILE-ASSOCIATED-DIARRHEA | THERAPY | pneumonia | MORBIDITY | FLUOROQUINOLONES | COHORT | OUTCOMES | community-acquired | PATHOGENS | Community-Acquired Infections - diagnosis | Triazoles - administration & dosage | Triazoles - adverse effects | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Microbial Sensitivity Tests | Community-Acquired Infections - drug therapy | Aged, 80 and over | Adult | Female | Anti-Bacterial Agents - adverse effects | Fluoroquinolones - administration & dosage | Pneumonia, Bacterial - microbiology | Macrolides - administration & dosage | Administration, Oral | Comorbidity | Treatment Outcome | Pneumonia, Bacterial - diagnosis | Fluoroquinolones - adverse effects | Macrolides - adverse effects | Administration, Intravenous | Pneumonia, Bacterial - drug therapy | Aged | Anti-Bacterial Agents - administration & dosage | Community-Acquired Infections - microbiology | Treatment outcome | Safety and security measures | Bacterial pneumonia | Analysis | Dosage and administration | Moxifloxacin | Comparative analysis | Drug therapy | Bacteria | Antibiotics | Medical treatment | Index Medicus
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 3, pp. e9836 - e9836
Antibiotic administration is the standard treatment for the bacterium Helicobacter pylori, the main causative agent of peptic ulcer disease and gastric cancer.... 
CLARITHROMYCIN | RESISTANCE GENES | INTESTINAL MICROFLORA | HELICOBACTER-PYLORI INFECTION | FLORA | PERSISTENCE | BIOLOGY | POPULATIONS | MACROLIDE RESISTANCE | GRADIENT GEL-ELECTROPHORESIS | 16S RIBOSOMAL-RNA | Oligonucleotides - genetics | Dyspepsia - drug therapy | Humans | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Gastrointestinal Tract - microbiology | Gastrointestinal Tract - drug effects | Drug Resistance, Microbial - genetics | Phylogeny | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Polymorphism, Restriction Fragment Length | Time Factors | Clarithromycin - administration & dosage | RNA, Ribosomal, 16S - genetics | Feces | Pharynx - drug effects | Pharynx - microbiology | Drug resistance in microorganisms | Care and treatment | Antibiotics | Microbiota (Symbiotic organisms) | RNA | Analysis | Peptic ulcer | Stomach cancer | Antiulcer drugs | Short term | Microbial activity | Clarithromycin | rRNA 16S | Microbiology | Genes | Colorectal cancer | Biology | Drug resistance | Gene polymorphism | Data bases | Microorganisms | Helicobacter pylori | Intestine | Antibiotic resistance | Phylogenetics | Bacteria | Gastric cancer | Deoxyribonucleic acid--DNA | Pharynx | Disease control | Bacteriology | Polymerase chain reaction | Infectious diseases | Restriction fragment length polymorphism | Metronidazole | Cancer | Long-term effects | Polymorphism | Index Medicus | ULCERS | ANTIBIOTICS | DISEASES | THERAPY | NEOPLASMS | GENES | FECES | COMMUNITIES | METRONIDAZOLE | Microbial/genetics | Ribosomal | Pharynx/drug effects/microbiology | Restriction Fragment Length | Gastrointestinal Tract/drug effects/microbiology | Clarithromycin/administration & dosage | Omeprazole/administration & dosage | Metronidazole/administration & dosage | Oligonucleotides/genetics | Naturvetenskap | Natural Sciences | Dyspepsia/drug therapy | 16S/genetics | Anti-Bacterial Agents/therapeutic use | Drug Resistance | Deoxyribonucleic acid | DNA
Journal Article
Journal of Infection and Chemotherapy, ISSN 1341-321X, 06/2018, Volume 24, Issue 6, pp. 414 - 421
Journal Article